Skip to main content
. Author manuscript; available in PMC: 2014 Nov 4.
Published in final edited form as: J Clin Oncol Res. 2014 Jan 15;2(1):http://www.jscimedcentral.com/Oncology/oncology-2-1004.php.

Figure 6.

Figure 6

A) VorinostatSAHA enhances TMZ-induced radiosensitization. Clonogenic survival assay as in Figure 1A) except that the D54 cells were treated with TMZ (51.5 μM) for 1h prior to radiation or radiation and VorinostatSAHA (1.5 μM) exposure. * = p<0.05 : TMZ/RAD/SAHA as compared to RAD, ‡ = p<0.05: TMZ/RAD/SAHA as compared to TMZ/RAD, † = p<0.05: TMZ/RAD as compared to RAD. B) RER by TMZ and TMZ plus SAHA calculated as in Figure 1.